B19 parvovirus is pathogenic in man and a vaccine is desirable. In con
valescence after acute infection, the dominant humoral immune response
is directed to the minor capsid protein called VP1, which differs fro
m the major capsid protein by an additional NH2-terminal 227 amino aci
ds. We have previously shown that this unique region contains multiple
linear neutralizing epitopes. We produced seven recombinant B19 capsi
ds that contained progressively truncated VP1 unique region sequences,
each fused to a Flag peptide (AspTyrLysAspAspAspAspLys) at the NH2-te
rminus. Capsids containing normal VP2 and truncated Flag-VP1 proteins
and, in some cases, only truncated Flag-VP1 chimeric proteins, were an
alyzed by ELISA, affinity chromatography, and electron microscopy usin
g anti-flag monoclonal antibody. All regions examined showed binding t
o anti-flag antibody in multiple assays, indicating that most of the V
P1 unique region is external to the capsid and accessible to antibody
binding. These results have implications for the design of a B19 parvo
virus vaccine and the use of empty capsids for presentation of heterol
ogous protein antigens. (C) 1995 Academic Press, Inc.